Leishmania lipophosphoglycan: How to establish structure-activity relationships for this highly complex and multifunctional glycoconjugate?

Frontiers in Cellular and Infection Microbiology

Volumn 4, Issue , 2014, Pages

  Forestier, Claire Lise ^a   Gao, Qi ^b   Boons, Geert Jan ^b  

^a AIX MARSEILLE UNIVERSITY   (France)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Chemical synthesis; Leishmania glycoconjugates; Lipophosphoglycan; LPG function; LPG structure; LPG structure activity relationships

Indexed keywords

GLYCOCONJUGATE; LIPOPHOSPHOGLYCAN;

ARTICLE; CELL WALL; GLYCOCALYX; HOST PARASITE INTERACTION; IMMUNE RESPONSE; LEISHMANIA; NONHUMAN; PARASITE SURVIVAL; PARASITE VIRULENCE; PARASITOSIS; PHAGOSOME; STRUCTURE ACTIVITY RELATION; VACCINATION; VACCINE IMMUNOGENICITY;

EID: 84990923182     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2014.00193     Document Type: Article

References (65)

1. Amprey, J. L., Im, J. S., Turco, S. J., Murray, H. W., Illarionov, P. A., Besra, G. S., et al. (2004). A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J. Exp. Med. 200, 895-904. doi: 10.1084/jem.20040704
2. Astronomo, R. D., and Burton, D. R. (2010). Carbohydrate vaccines: developing sweet solutions to sticky situations? Nat. Rev. Drug Discov. 9, 308-324. doi: 10.1038/nrd3012
3. Bahr, V., Stierhof, Y. D., Ilg, T., Demar, M., Quinten, M., and Overath, P. (1993). Expression of lipophosphoglycan, high-molecular weight phosphoglycan and glycoprotein 63 in promastigotes and amastigotes of Leishmania mexicana. Mol. Biochem. Parasitol. 58, 107-121. doi: 10.1016/0166-6851(93)90095-F
4. Becker, I., Salaiza, N., Aguirre, M., Delgado, J., Carrillo-Carrasco, N., Kobeh, L. G., et al. (2003). Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Mol. Biochem. Parasitol. 130, 65-74. doi: 10.1016/S0166-6851(03)00160-9
5. Beverley, S. M., and Turco, S. J. (1998). Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania. Tr e n d s Microbiol. 6, 35-40. doi: 10.1016/S0966-842X(97)01180-3
6. Campos, M. A., Almeida, I. C., Takeuchi, O., Akira, S., Valente, E. P., Procopio, D. O., et al. (2001). Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 167, 416-423. doi: 10.4049/jimmunol.167.1.416
7. Capul, A. A., Barron, T., Dobson, D. E., Turco, S. J., and Beverley, S. M. (2007a). Two functionally divergent UDP-Gal nucleotide sugar transporters participate in phosphoglycan synthesis in Leishmania major. J. Biol. Chem. 282, 14006-14017. doi: 10.1074/jbc.M610869200
8. Capul, A. A., Hickerson, S., Barron, T., Turco, S. J., and Beverley, S. M. (2007b). Comparisons of mutants lacking the Golgi UDP-galactose or GDP-mannose transporters establish that phosphoglycans are important for promastigote but not amastigote virulence in Leishmania major. Infect. Immun. 75, 4629-4637. doi: 10.1128/IAI.00735-07
9. Chandra, D., and Naik, S. (2008). Leishmania donovani infection downregulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage/monocytic lineage by modulating MAPK pathways through a contact-dependent mechanism. Clin. Exp. Immunol. 154, 224-234. doi: 10.1111/j.1365-2249.2008.03741.x
10. Coelho-Finamore, J. M., Freitas, V. C., Assis, R. R., Melo, M. N., Novozhilova, N., Secundino, N. F., et al. (2011). Leishmania infantum: Lipophosphoglycan intraspecific variation and interaction with vertebrate and invertebrate hosts. Int. J. Parasitol. 41, 333-342. doi: 10.1016/j.ijpara.2010.10.004
11. De Assis, R. R., Ibraim, I. C., Nogueira, P. M., Soares, R. P., and Turco, S. J. (2012). Glycoconjugates in New World species of Leishmania: polymorphisms in lipophosphoglycan and glycoinositolphospholipids and interaction with hosts. Biochim. Biophys. Acta 1820, 1354-1365. doi: 10.1016/j.bbagen.2011.11.001
12. De Veer, M. J., Curtis, J. M., Baldwin, T. M., Didonato, J. A., Sexton, A., Mcconville, M. J., et al. (2003). MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling. Eur. J. Immunol. 33, 2822-2831. doi: 10.1002/eji.200324128
13. Dermine, J. F., Goyette, G., Houde, M., Turco, S. J., and Desjardins, M. (2005). Leishmania donovani lipophosphoglycan disrupts phagosome microdomains in J774 macrophages. Cell Microbiol. 7, 1263-1270. doi: 10.1111/j.1462-5822.2005.00550.x
14. Descoteaux, A., Avila, H. A., Zhang, K., Turco, S. J., and Beverley, S. M. (2002). Leishmania LPG3 encodes a GRP94 homolog required for phosphoglycan synthesis implicated in parasite virulence but not viability. EMBO J. 21, 4458-4469. doi: 10.1093/emboj/cdf447
15. Descoteaux, A., and Turco, S. J. (1999). Glycoconjugates in Leishmania infectivity. Biochim. Biophys. Acta 1455, 341-352. doi: 10.1016/S0925-4439(99)00065-4
16. Desjardins, M., and Descoteaux, A. (1997). Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J. Exp. Med. 185, 2061-2068. doi: 10.1084/jem.185.12.2061
17. Dobson, D. E., Kamhawi, S., Lawyer, P., Turco, S. J., Beverley, S. M., and Sacks, D. L. (2010). Leishmania major survival in selective Phlebotomus papatasi sand fly vector requires a specific SCG-encoded lipophosphoglycan galactosylation pattern. PLoS Pathog. 6:e1001185. doi: 10.1371/journal.ppat.1001185
18. Dobson, D. E., Scholtes, L. D., Myler, P. J., Turco, S. J., and Beverley, S. M. (2006). Genomic organization and expression of the expanded SCG/L/R gene family of Leishmania major: internal clusters and telomeric localization of SCGs mediating species-specific LPG modifications. Mol. Biochem. Parasitol. 146, 231-241. doi: 10.1016/j.molbiopara.2005.12.012
19. Ferguson, M. A. (1999). The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research. J. Cell Sci. 112(Pt 17), 2799-2809.
20. Forestier, C. L. (2013). Imaging host-Leishmania interactions: significance in visceral leishmaniasis. Parasite Immunol. 35, 256-266. doi: 10.1111/pim. 12044
21. Forestier, C. L., Machu, C., Loussert, C., Pescher, P., and Spath, G. F. (2011). Imaging host cell-Leishmania interaction dynamics implicates parasite motility, lysosome recruitment, and host cell wounding in the infection process. Cell Host Microbe 9, 319-330. doi: 10.1016/j.chom.2011.03.011
22. Garami, A., Mehlert, A., and Ilg, T. (2001). Glycosylation defects and virulence phenotypes of Leishmania mexicana phosphomannomutase and dolicholphosphate-mannose synthase gene deletion mutants. Mol. Cell Biol. 21, 8168-8183. doi: 10.1128/MCB.21.23.8168-8183.2001
23. Goel, A., Vohra, H., and Varshney, G. C. (1999). Strain-specific recognition of live Leishmania donovani promastigotes by homologous antiserum raised against a crude membrane fraction of infected macrophages. Parasitol. Res. 85, 19-24. doi: 10.1007/s004360050501
24. Handman, E., and Mitchell, G. F. (1985). Immunization with Leishmania receptor for macrophages protects mice against cutaneous leishmaniasis. Proc. Natl. Acad. Sci. U.S.A. 82, 5910-5914. doi: 10.1073/pnas.82.17.5910
25. Hewitt, M. C., and Seeberger, P. H. (2001). Solution and solid-support synthesis of a potential leishmaniasis carbohydrate vaccine. J. Org. Chem. 66, 4233-4243. doi: 10.1021/jo015521z
26. Hilley, J. D., Zawadzki, J. L., Mcconville, M. J., Coombs, G. H., and Mottram, J. C. (2000). Leishmania mexicana mutants lacking glycosylphosphatidylinositol (GPI):protein transamidase provide insights into the biosynthesis and functions of GPI-anchored proteins. Mol. Biol. Cell 11, 1183-1195. doi: 10.1091/mbc.11.4.1183
27. Ibraim, I. C., De Assis, R. R., Pessoa, N. L., Campos, M. A., Melo, M. N., Turco, S. J., et al. (2013). Two biochemically distinct lipophosphoglycans from Leishmania braziliensis and Leishmania infantum trigger different innate immune responses in murine macrophages. Parasit. Vectors 6:54. doi: 10.1186/1756-3305-6-54
28. Ilg, T. (2000). Proteophosphoglycans of Leishmania. Parasitol. Today 16, 489-497. doi: 10.1016/S0169-4758(00)01791-9
29. Ilgoutz, S. C., Zawadzki, J. L., Ralton, J. E., and Mcconville, M. J. (1999). Evidence that free GPI glycolipids are essential for growth of Leishmania mexicana. EMBO J. 18, 2746-2755. doi: 10.1093/emboj/18.10.2746
30. Karanja, R., Ingonga, J., Mwangi, M., Mwala, D., Lugalia, R., Magambo, J., et al. (2011). Immunization with a combination of Leishmania major lipophosphoglycan (LPG) and Phlebotomus duboscqui salivary gland lysates (SGLs) abrogates protective effect of LPG against L. major in BALB/C mice. Afr. J. Health Sci. 18, 1-5.
31. Kavoosi, G., Ardestani, S. K., and Kariminia, A. (2009). The involvement of TLR2 in cytokine and reactive oxygen species (ROS) production by PBMCs in response to Leishmania major phosphoglycans (PGs). Parasitolog y 136, 1193-1199. doi: 10.1017/S0031182009990473
32. Liu, D., Kebaier, C., Pakpour, N., Capul, A. A., Beverley, S. M., Scott, P., et al. (2009). Leishmania major phosphoglycans influence the host early immune response by modulating dendritic cell functions. Infect. Immun. 77, 3272-3283. doi: 10.1128/IAI.01447-08
33. Lodge, R., and Descoteaux, A. (2005). Leishmania donovani promastigotes induce periphagosomal F-actin accumulation through retention of the GTPase Cdc42. Cell Microbiol. 7, 1647-1658. doi: 10.1111/j.1462-5822.2005.00582.x
34. Ma, D., Russell, D. G., Beverley, S. M., and Turco, S. J. (1997). Golgi GDPmannose uptake requires Leishmania LPG2. A member of a eukaryotic family of putative nucleotide-sugar transporters. J. Biol. Chem. 272, 3799-3805. doi: 10.1074/jbc.272.6.3799
35. Martinez Salazar, M. B., Delgado Dominguez, J., Silva Estrada, J., Gonzalez Bonilla, C., and Becker, I. (2014). Vaccination with Leishmania mexicana LPG induces PD-1 in CD8(+) and PD-L2 in macrophages thereby suppressing the immune response: a model to assess vaccine efficacy. Vaccine 32, 1259-1265. doi: 10.1016/j.vaccine.2014.01.016
36. Mcconville, M. J., Collidge, T. A., Ferguson, M. A., and Schneider, P. (1993). The glycoinositol phospholipids of Leishmania mexicana promastigotes. Evidence for the presence of three distinct pathways of glycolipid biosynthesis. J. Biol. Chem. 268, 15595-15604.
37. Mcconville, M. J., and Ferguson, M. A. (1993). The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes. Biochem. J. 294(Pt 2), 305-324.
38. Mensa-Wilmot, K., Lebowitz, J. H., Chang, K. P., Al-Qahtani, A., Mcgwire, B. S., Tucker, S., et al. (1994). A glycosylphosphatidylinositol (GPI)-negative phenotype produced in Leishmania major by GPI phospholipase C from Trypanosoma brucei: topography of two GPI pathways. J. Cell. Biol. 124, 935-947. doi: 10.1083/jcb.124.6.935
39. Moll, H., Mitchell, G. F., Mcconville, M. J., and Handman, E. (1989). Evidence of T-cell recognition in mice of a purified lipophosphoglycan from Leishmania major. Infect. Immun. 57, 3349-3356.
40. Moll, H., and Rollinghoff, M. (1991). T-cell reactivity to purified lipophosphoglycan from Leishmania major: a model for analysis of the cellular immune response to microbial carbohydrates. Behring Inst. Mitt. 88, 161-169.
41. Phillips, M. R., and Turco, S. J. (2014). Characterization of a ricin-resistant mutant of Leishmania donovani that expresses Lipophosphoglycan. Glycobiology. doi: 10.1093/glycob/cwu130. [Epub ahead of print].
42. Pinheiro, R. O., Pinto, E. F., De Matos Guedes, H. L., Filho, O. A., De Mattos, K. A., Saraiva, E. M., et al. (2007). Protection against cutaneous leishmaniasis by intranasal vaccination with lipophosphoglycan. Vaccine 25, 2716-2722. doi: 10.1016/j.vaccine.2006.05.093
43. Pinheiro, R. O., Pinto, E. F., Lopes, J. R., Guedes, H. L., Fentanes, R. F., and Rossi-Bergmann, B. (2005). TGF-beta-associated enhanced susceptibility to leishmaniasis following intramuscular vaccination of mice with Leishmania amazonensis antigens. Microbes Infect. 7, 1317-1323. doi: 10.1016/j.micinf.2005.04.016
44. Puentes, S. M., Da Silva, R. P., Sacks, D. L., Hammer, C. H., and Joiner, K. A. (1990). Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9. J. Immunol. 145, 4311-4316.
45. Puentes, S. M., Dwyer, D. M., Bates, P. A., and Joiner, K. A. (1989). Binding and release of C3 from Leishmania donovani promastigotes during incubation in normal human serum. J. Immunol. 143, 3743-3749.
46. Rojas-Bernabe, A., Garcia-Hernandez, O., Maldonado-Bernal, C., Delegado-Dominguez, J., Ortega, E., Gutierrez-Kobeh, L., et al. (2014). Leishmania mexicana lipophosphoglycan activates ERK and p38 MAP kinase and induces production of proinflammatory cytokines in human macrophages through TLR2 and TLR4. Parasitolog y 141, 788-800. doi: 10.1017/S0031182013002187
47. Routier, F. H., Nikolaev, A. V., and Ferguson, M. A. (1999). The preparation of neoglycoconjugates containing inter-saccharide phosphodiester linkages as potential anti-Leishmania vaccines. Glycoconj. J. 16, 773-780. doi: 10.1023/A:1007171613195
48. Russell, D. G., and Alexander, J. (1988). Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes. J. Immunol. 140, 1274-1279.
49. Ryan, K. A., Garraway, L. A., Descoteaux, A., Turco, S. J., and Beverley, S. M. (1993). Isolation of virulence genes directing surface glycosyl-phosphatidylinositol synthesis by functional complementation of Leishmania. Proc. Natl. Acad. Sci. U.S.A. 90, 8609-8613. doi: 10.1073/pnas.90.18.8609
50. Sacks, D. L., Brodin, T. N., and Turco, S. J. (1990). Developmental modification of the lipophosphoglycan from Leishmania major promastigotes during metacyclogenesis. Mol. Biochem. Parasitol. 42, 225-233. doi: 10.1016/0166-6851(90)90165-I
51. Sacks, D. L., Pimenta, P. F., Mcconville, M. J., Schneider, P., and Turco, S. J. (1995). Stage-specific binding of Leishmania donovani to the sand fly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglycan. J. Exp. Med. 181, 685-697. doi: 10.1084/jem.181.2.685
52. Soares, R. P., Macedo, M. E., Ropert, C., Gontijo, N. F., Almeida, I. C., Gazzinelli, R. T., et al. (2002). Leishmania chagasi: lipophosphoglycan characterization and binding to the midgut of the sand fly vector Lutzomyia longipalpis. Mol. Biochem. Parasitol. 121, 213-224. doi: 10.1016/S0166-6851(02)00033-6
53. Spath, G. F., Epstein, L., Leader, B., Singer, S. M., Avila, H. A., Turco, S. J., et al. (2000). Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proc. Natl. Acad. Sci. U.S.A. 97, 9258-9263. doi: 10.1073/pnas.160257897
54. Spath, G. F., Garraway, L. A., Turco, S. J., and Beverley, S. M. (2003). The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proc. Natl. Acad. Sci. U.S.A. 100, 9536-9541. doi: 10.1073/pnas.1530604100
55. Srivastava, S., Pandey, S. P., Jha, M. K., Chandel, H. S., and Saha, B. (2013). Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses. Clin. Exp. Immunol. 172, 403-409. doi: 10.1111/cei.12074
56. Tolson, D. L., Turco, S. J., and Pearson, T. W. (1990). Expression of a repeating phosphorylated disaccharide lipophosphoglycan epitope on the surface of macrophages infected with Leishmania donovani. Infect. Immun. 58, 3500-3507.
57. Tonui, W. K., Mpoke, S. S., Orago, A. S., Turco, S. J., Mbati, P. A., and Mkoji, G. M. (2003). Leishmania donovani-derived lipophosphoglycan plus BCG induces a Th1 type immune response but does not protect Syrian golden hamsters (Mesocricetus auratus) and BALB/c mice against Leishmania donovani. Onderstepoort J. Vet. Res. 70, 255-263. doi: 10.4102/ojvr.v70i4.290
58. Topuzogullari, M., Cakir Koc, R., Dincer Isoglu, S., Bagirova, M., Akdeste, Z., Elcicek, S., et al. (2013). Conjugation, characterization and toxicity of lipophosphoglycan-polyacrylic acid conjugate for vaccination against leishmaniasis. J. Biomed. Sci. 20, 35. doi: 10.1186/1423-0127-20-35
59. Turco, S. J., and Descoteaux, A. (1992). The lipophosphoglycan of Leishmania parasites. Annu. Rev. Microbiol. 46, 65-94. doi: 10.1146/annurev.mi.46. 100192.000433
60. Turco, S. J., and Sacks, D. L. (1991). Expression of a stage-specific lipophosphoglycan in Leishmania major amastigotes. Mol. Biochem. Parasitol. 45, 91-99. doi: 10.1016/0166-6851(91)90030-A
61. Turco, S. J., Spath, G. F., and Beverley, S. M. (2001). Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species. Tr e n d s Pa r a s i t o l . 17, 223-226. doi: 10.1016/S1471-4922(01)01895-5
62. Vinet, A. F., Fukuda, M., Turco, S. J., and Descoteaux, A. (2009). The Leishmania donovani lipophosphoglycan excludes the vesicular proton-ATPase from phagosomes by impairing the recruitment of synaptotagmin V. PLoS Pathog. 5:e1000628. doi: 10.1371/journal.ppat.1000628
63. Volf, P., Nogueira, P. M., Myskova, J., Turco, S. J., and Soares, R. P. (2014). Structural comparison of lipophosphoglycan from Leishmania turanica and L. major, two species transmitted by Phlebotomus papatasi. Parasitol. Int. 63, 683-686. doi: 10.1016/j.parint.2014.05.004
64. Winberg, M. E., Holm, A., Sarndahl, E., Vinet, A. F., Descoteaux, A., Magnusson, K. E., et al. (2009). Leishmania donovani lipophosphoglycan inhibits phagosomal maturation via action on membrane rafts. Microbes Infect. 11, 215-222. doi: 10.1016/j.micinf.2008.11.007
65. Zufferey, R., Allen, S., Barron, T., Sullivan, D. R., Denny, P. W., Almeida, I. C., et al. (2003). Ether phospholipids and glycosylinositolphospholipids are not required for amastigote virulence or for inhibition of macrophage activation by Leishmania major. J. Biol. Chem. 278, 44708-44718. doi: 10.1074/jbc.M308063200